Listeria Monocytogenes Infections Treatment Global Market Report 2024

Listeria Monocytogenes Infections Treatment Global Market Report 2024 – By Drug Class (Ampicillin, Gentamicin, Vancomycin, Other Drug Classes), By Type Of Infection ( Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess), By Mode Of Administration (Oral, Injectable, Other Mode Of Administrations), By End Users (Hospitals, Home Care, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Listeria Monocytogenes Infections Treatment Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Listeria Monocytogenes Infections Treatment Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Listeria Monocytogenes Infections Treatment Market Definition

Listeria monocytogenes infection treatment refers to the medical interventions and therapeutic measures employed to combat and manage infections caused by the bacterium listeria monocytogenes. Listeria monocytogenes is a pathogenic bacterium that can cause a severe illness known as listeriosis in humans. Listeriosis typically occurs when individuals consume contaminated food or beverages that contain listeria monocytogenes.

The main classes of drugs used for listeria monocytogenes infections treatment are Ampicillin, Gentamicin, Vancomycin, and others. Several types of infections include gastroenteritis, endocarditis, meningitis, bacteremia, and brain abscess. The drugs can be administered through various modes, such as oral, injectable, and other modes and are used by several end users, including hospitals, home care, specialty clinics, and others.

Listeria Monocytogenes Infections Treatment Market Segmentation

The listeria monocytogenes infections treatment market covered in this report is segmented –

1) By Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes

2) By Type Of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess

3) By Mode Of Administration : Oral, Injectable, Other Mode Of Administrations

4) By End Users: Hospitals, Home Care, Speciality Clinics, Other End Users

Global Listeria Monocytogenes Infections Treatment Market Size 2023 to 2028: Graph

Listeria Monocytogenes Infections Treatment Market Size 2024 And Growth Rate

The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased food safety regulations, increased incidence of foodborne illnesses, advancements in diagnostics, awareness programs and education, healthcare infrastructure development..

Listeria Monocytogenes Infections Treatment Market Growth Forecast

The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to globalization of food supply chains, research and development in antimicrobials, changing dietary patterns, international collaboration in healthcare, public health preparedness.. Major trends in the forecast period include application of combination therapies, enhanced diagnostic tools, focus on prevention and prophylaxis, collaborative research initiatives, regulatory framework development..

Listeria Monocytogenes Infections Treatment Market Driver: Rising Incidence Of Foodborne Diseases Drive The Listeria Monocytogenes Infection Treatment Market

The rising incidence of foodborne diseases is expected to propel the growth of the listeria monocytogenes infection treatment going forward. Foodborne diseases, also known as foodborne illnesses or food poisoning, refer to diseases caused by consuming contaminated food or beverages. Listeria monocytogenes infections caused by the bacterium Listeria monocytogenes, can be a significant concern in foodborne illnesses because this bacterium can contaminate various foods. The treatment for listeria monocytogenes infections reduces the risk factors and severity associated with the disease. For instance, in December 2022, according to the European Food Safety Authority, an Italy-based independent agency for providing scientific advice on food and feed safety, nutrition, and related issues, there were around 4,005 foodborne incidents in 2021, an increase of 29.8% compared to 2020. Therefore, the rising incidence of foodborne diseases is driving the growth of the listeria monocytogenes infection treatment.

Listeria Monocytogenes Infections Treatment Market Driver: Government-Led Healthcare Research And Development Initiatives A Boost For Listeria Monocytogenes Infection Treatment

Government initiatives for research and development in healthcare are expected to propel the growth of the growth of the listeria monocytogenes infection treatment market going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels (local, regional, national, or international) to address specific issues, achieve certain goals, or create positive changes in society. Several government authorities are initiating various healthcare initiatives to support various aspects including listeria monocytogenes infection treatment. For instance, in 2022, according to the Department of Health and Social Care, a UK-based government authority, the UK government announced £260 million (US $270.65) million in funding to boost healthcare research and manufacturing. This was committed by BEIS and DHSC to support NHS-led health research into diagnostics and treatment through new privacy-preserving platforms and clinical research services, and £60 million (US $63.60 million) to help expand life sciences manufacturing in the UK. Therefore, government initiatives for healthcare research and development drive the listeria monocytogenes infection treatment market.

Healthcare Expenditure's Impact On Driving The Listeria Monocytogenes Infection Treatment Market

The rising healthcare expenditure is anticipated to drive the expansion of the listeria monocytogenes infection treatment market in the future. Healthcare expenditure refers to spending on healthcare costs and represents the total amount of money spent on healthcare-related goods and services within a given healthcare system or economy. Healthcare expenditure plays a crucial role in supporting the development, accessibility, and of listeria monocytogenes infection treatment. For instance, in November 2022, according to the Canadian Institute for Health Information, a US-based not-for-profit organization, healthcare expenditure rose to 0.8%, which is $331 billion in 2022, and it was 7.6% in 2021. Therefore, rising healthcare expenditure is driving the growth of the listeria monocytogenes infection treatment market.

Global Listeria Monocytogenes Infections Treatment Market Major Players

Major companies operating in the listeria monocytogenes infections treatment market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Biogen Inc., Vertex Pharmaceuticals Incorporated, Fresenius Kabi AG, Aurobindo Pharma Ltd, Amneal Pharmaceuticals LLC, Lupin Ltd., ZydusCadila Health Care Ltd., Emergent Bio Solutions Inc., Wockhardt Ltd., Hainan Poly Pharm Co. Ltd., Novel Laboratories Inc., Bionpharma Inc., LimmaTech Biologics AG

Global Listeria Monocytogenes Infections Treatment Market Trend: Innovative Solutions Driving Growth In The Listeria Monocytogenes Infections Treatment Market

Major companies operating in the listeria monocytogenes infections treatment market are focusing on developing innovative products such as Microgen Listeria-ID to drive revenues in the market. Microgen Listeria-ID is a microbiological test designed to detect and confirm the presence of Listeria bacteria in food and other environmental samples. This comprehensive identification technique enables laboratories to identify and differentiate Listeria spp species without additional materials correctly. For instance, in April 2023, Gold Standard Diagnostics, a US-based company specializing in diagnostic test systems and services, launched Microgen Listeria-ID. The primary use of Microgen Listeria-ID is to identify Listeria monocytogenes for quality control and monitoring purposes in food processing facilities. Microgen Listeria-ID is known for its rapid and reliable identification of Listeria species. It can provide results in a shorter time compared to traditional culture-based methods.

Listeria Monocytogenes Infections Treatment Market Merger And Acquisition: Team Arnav Foundation Partners With Os Therapies To Support Phase Iib Trial Of Ost-Her2 In Osteosarcoma

In September 2022, Team Arnav Foundation, a US-based nonprofit group focused on finding treatment for juvenile sarcoma cancer, partnered with OS Therapies LLC. With this partnership, Team Arnav Foundation supports the phase IIb trial of OST-HER2 (Listeria monocytogenes) in recurrent, resected osteosarcoma. Additionally, Team Arnav's primary mission is to fund research that would lead to better treatments, higher cure rates, and reduced side effects for patients with malignant bone and soft tissue cancers. OS Therapies LLC is a US-based clinical-stage therapeutic company that develops immunotherapies based on live attenuated listeria monocytogenes (Lm) for solid tumors such as osteosarcoma.

Regional Outlook For The Global Listeria Monocytogenes Infections Treatment Market

North America was the largest region in the listeria monocytogenes infections treatment market in 2023. The regions covered in the listeria monocytogenes infections treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the listeria monocytogenes infections treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The listeria monocytogenes infections treatment market consists of revenues earned by entities by provide services such as diagnosis, antibiotic therapy, medical consultations, and nutritional support. The market value includes the value of related goods sold by the service provider or included within the service offering. The listeria monocytogenes infections treatment market also includes sales of penicillin G, meropenem, and trimethoprim-sulfamethoxazole (TMP-SMX). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The listeria monocytogenes infections treatment market research report is one of a series of new reports from The Business Research Company that provides listeria monocytogenes infections treatment market statistics, including listeria monocytogenes infections treatment industry global market size, regional shares, competitors with a listeria monocytogenes infections treatment market share, detailed listeria monocytogenes infections treatment market segments, market trends and opportunities, and any further data you may need to thrive in the listeria monocytogenes infections treatment industry. This listeria monocytogenes infections treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Listeria Monocytogenes Infections Treatment Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $4.79 billion
Revenue Forecast In 2033 $5.86 billion
Growth Rate CAGR of 5.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes
2) By Type Of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess
3) By Mode Of Administration: Oral, Injectable, Other Mode Of Administrations
4) By End Users: Hospitals, Home Care, Specialty Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; AstraZeneca plc; GlaxoSmithKline plc; Eli Lilly and Company; Gilead Sciences Inc.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals Inc.; Mylan N.V.; Biogen Inc.; Vertex Pharmaceuticals Incorporated; Fresenius Kabi AG; Aurobindo Pharma Ltd; Amneal Pharmaceuticals LLC; Lupin Ltd.; ZydusCadila Health Care Ltd.; Emergent Bio Solutions Inc.; Wockhardt Ltd.; Hainan Poly Pharm Co. Ltd.; Novel Laboratories Inc.; Bionpharma Inc.; LimmaTech Biologics AG
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Listeria Monocytogenes Infections Treatment Market Characteristics

    3. Listeria Monocytogenes Infections Treatment Market Trends And Strategies

    4. Listeria Monocytogenes Infections Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Listeria Monocytogenes Infections Treatment Market Size and Growth

    5.1. Global Listeria Monocytogenes Infections Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Listeria Monocytogenes Infections Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Listeria Monocytogenes Infections Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Listeria Monocytogenes Infections Treatment Market Segmentation

    6.1. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Ampicillin

    Gentamicin

    Vancomycin

    Other Drug Classes

    6.2. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gastroenteritis

    Endocarditis

    Meningitis

    Bacteremia

    Brain Abscess

    6.3. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Injectable

    Other Mode Of Administrations

    6.4. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Home Care

    Specialty Clinics

    Other End Users

    7. Listeria Monocytogenes Infections Treatment Market Regional And Country Analysis

    7.1. Global Listeria Monocytogenes Infections Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Listeria Monocytogenes Infections Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Listeria Monocytogenes Infections Treatment Market

    8.1. Asia-Pacific Listeria Monocytogenes Infections Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Listeria Monocytogenes Infections Treatment Market

    9.1. China Listeria Monocytogenes Infections Treatment Market Overview

    9.2. China Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Listeria Monocytogenes Infections Treatment Market

    10.1. India Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Listeria Monocytogenes Infections Treatment Market

    11.1. Japan Listeria Monocytogenes Infections Treatment Market Overview

    11.2. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Listeria Monocytogenes Infections Treatment Market

    12.1. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Listeria Monocytogenes Infections Treatment Market

    13.1. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Listeria Monocytogenes Infections Treatment Market

    14.1. South Korea Listeria Monocytogenes Infections Treatment Market Overview

    14.2. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Listeria Monocytogenes Infections Treatment Market

    15.1. Western Europe Listeria Monocytogenes Infections Treatment Market Overview

    15.2. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Listeria Monocytogenes Infections Treatment Market

    16.1. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Listeria Monocytogenes Infections Treatment Market

    17.1. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Listeria Monocytogenes Infections Treatment Market

    18.5. France Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Listeria Monocytogenes Infections Treatment Market

    19.9. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Listeria Monocytogenes Infections Treatment Market

    20.13. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Listeria Monocytogenes Infections Treatment Market

    21.1. Eastern Europe Listeria Monocytogenes Infections Treatment Market Overview

    21.2. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Listeria Monocytogenes Infections Treatment Market

    22.1. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Listeria Monocytogenes Infections Treatment Market

    23.1. North America Listeria Monocytogenes Infections Treatment Market Overview

    23.2. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Listeria Monocytogenes Infections Treatment Market

    24.1. USA Listeria Monocytogenes Infections Treatment Market Overview

    24.2. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Listeria Monocytogenes Infections Treatment Market

    25.1. Canada Listeria Monocytogenes Infections Treatment Market Overview

    25.2. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Listeria Monocytogenes Infections Treatment Market

    26.1. South America Listeria Monocytogenes Infections Treatment Market Overview

    26.2. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Listeria Monocytogenes Infections Treatment Market

    27.1. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Listeria Monocytogenes Infections Treatment Market

    28.1. Middle East Listeria Monocytogenes Infections Treatment Market Overview

    28.2. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Listeria Monocytogenes Infections Treatment Market

    29.1. Africa Listeria Monocytogenes Infections Treatment Market Overview

    29.2. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Listeria Monocytogenes Infections Treatment Market Competitive Landscape And Company Profiles

    30.1. Listeria Monocytogenes Infections Treatment Market Competitive Landscape

    30.2. Listeria Monocytogenes Infections Treatment Market Company Profiles

    30.2.1. Emergent Bio Solutions Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. LimmaTech Biologics AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. GlaxoSmithKline plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. ZydusCadila Health Care Ltd

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Listeria Monocytogenes Infections Treatment Market Competitive Benchmarking

    32. Global Listeria Monocytogenes Infections Treatment Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Listeria Monocytogenes Infections Treatment Market

    34. Listeria Monocytogenes Infections Treatment Market Future Outlook and Potential Analysis

    34.1 Listeria Monocytogenes Infections Treatment Market In 2028 - Countries Offering Most New Opportunities

    34.2 Listeria Monocytogenes Infections Treatment Market In 2028 - Segments Offering Most New Opportunities

    34.3 Listeria Monocytogenes Infections Treatment Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Listeria Monocytogenes Infections Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Listeria Monocytogenes Infections Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Emergent Bio Solutions Inc. Financial Performance
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: LimmaTech Biologics AG Financial Performance
  • Table 78: GlaxoSmithKline plc Financial Performance
  • Table 79: ZydusCadila Health Care Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Listeria Monocytogenes Infections Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Listeria Monocytogenes Infections Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Emergent Bio Solutions Inc. Financial Performance
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: LimmaTech Biologics AG Financial Performance
  • Figure 78: GlaxoSmithKline plc Financial Performance
  • Figure 79: ZydusCadila Health Care Ltd Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the listeria monocytogenes infections treatment market?

Listeria monocytogenes infection treatment refers to the medical interventions and therapeutic measures employed to combat and manage infections caused by the bacterium listeria monocytogenes. Listeria monocytogenes is a pathogenic bacterium that can cause a severe illness known as listeriosis in humans. Listeriosis typically occurs when individuals consume contaminated food or beverages that contain listeria monocytogenes. For further insights on the listeria monocytogenes infections treatment market, request a sample here

How will the listeria monocytogenes infections treatment market drivers and restraints affect the listeria monocytogenes infections treatment market dynamics? What forces will shape the listeria monocytogenes infections treatment industry going forward?

The listeria monocytogenes infections treatment market major growth driver - Rising Incidence Of Foodborne Diseases Drive The Listeria Monocytogenes Infection Treatment Market. For further insights on the listeria monocytogenes infections treatment market, request a sample here

What is the forecast market size or the forecast market value of the listeria monocytogenes infections treatment market?

The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased food safety regulations, increased incidence of foodborne illnesses, advancements in diagnostics, awareness programs and education, healthcare infrastructure development.. The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to globalization of food supply chains, research and development in antimicrobials, changing dietary patterns, international collaboration in healthcare, public health preparedness.. Major trends in the forecast period include application of combination therapies, enhanced diagnostic tools, focus on prevention and prophylaxis, collaborative research initiatives, regulatory framework development.. For further insights on the listeria monocytogenes infections treatment market, request a sample here

How is the listeria monocytogenes infections treatment market segmented?

The listeria monocytogenes infections treatment market is segmented
1) By Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes
2) By Type Of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess
3) By Mode Of Administration : Oral, Injectable, Other Mode Of Administrations
4) By End Users: Hospitals, Home Care, Speciality Clinics, Other End UsersFor further insights on the listeria monocytogenes infections treatment market,
request a sample here

Which region has the largest share of the listeria monocytogenes infections treatment market? What are the other regions covered in the report?

North America was the largest region in the listeria monocytogenes infections treatment market in 2023. The regions covered in the listeria monocytogenes infections treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the listeria monocytogenes infections treatment market, request a sample here.

Who are the major players in the listeria monocytogenes infections treatment market?

Major companies operating in the listeria monocytogenes infections treatment market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Biogen Inc., Vertex Pharmaceuticals Incorporated, Fresenius Kabi AG, Aurobindo Pharma Ltd, Amneal Pharmaceuticals LLC, Lupin Ltd., ZydusCadila Health Care Ltd., Emergent Bio Solutions Inc., Wockhardt Ltd., Hainan Poly Pharm Co. Ltd., Novel Laboratories Inc., Bionpharma Inc., LimmaTech Biologics AG For further insights on the listeria monocytogenes infections treatment market, request a sample here.

What are the key trends in the listeria monocytogenes infections treatment market?

Major trend in the listeria monocytogenes infections treatment market - Rising Incidence Of Foodborne Diseases Drive The Listeria Monocytogenes Infection Treatment Market. For further insights on the listeria monocytogenes infections treatment market, request a sample here.

What are the major opportunities in the listeria monocytogenes infections treatment market? What are the strategies for the listeria monocytogenes infections treatment market?

For detailed insights on the major opportunities and strategies in the listeria monocytogenes infections treatment market, request a sample here.

How does the listeria monocytogenes infections treatment market relate to the overall economy and other similar markets?

For detailed insights on listeria monocytogenes infections treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the listeria monocytogenes infections treatment industry?

For detailed insights on the mergers and acquisitions in the listeria monocytogenes infections treatment industry, request a sample here.

What are the key dynamics influencing the listeria monocytogenes infections treatment market growth? SWOT analysis of the listeria monocytogenes infections treatment market.

For detailed insights on the key dynamics influencing the listeria monocytogenes infections treatment market growth and SWOT analysis of the listeria monocytogenes infections treatment industry, request a sample here.